¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå - ½ÃÇè µðÀÚÀκ°, À¯Çüº°, ´Ü°èº°, ÀûÀÀÁõº°, »ê¾÷º° ¿¹Ãø(2024-2032³â)
Virtual Clinical Trials Market - By Study Design, Type, Phases, Indication, Industry - Global Forecast 2024 - 2032
»óǰÄÚµå : 1485254
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 210 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¡»ó ÀÓ»ó½ÃÇè ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.1%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µðÁöÅÐ °Ç°­ ±â¼ú°ú ¿ø°Ý ÀÇ·á Áøº¸·Î ¿ø°ÝÁö¿¡¼­ µ¥ÀÌÅÍ ¼öÁý, ¸ð´ÏÅ͸µ ¹× ȯÀÚ Âü¿©°¡ °¡´ÉÇØÁö¸é¼­ ¹°¸®Àû ½Ã¼³ ¹æ¹®ÀÇ Çʿ伺ÀÌ ÁÙ¾îµé¾î Àüü ºñ¿ëÀÌ Àý°¨µË´Ï´Ù. µû¶ó¼­ °¡»ó ÀÓ»ó½ÃÇèÀº Âü°¡Àڵ鿡°Ô º¸´Ù Á¢±ÙÀÌ ¿ëÀÌÇÏ°í Æí¸®¼ºÀÌ ³ô±â ¶§¹®¿¡ ȯÀÚÀÇ ¸ðÁý, À¯Áö, ´Ù¾ç¼º °³¼±À¸·Î À̾îÁ® Å©°Ô º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.

2023³â 10¿ù Elligo Health Research´Â Avallano¿Í Çù·ÂÇÏ¿© AI ÁÖµµ ÀÓ»ó½ÃÇè ¸ðÁý ¹× Âü¿© Ç÷§ÆûÀÎ myTrialsConnect¸¦ µµÀÔÇÏ¿© ȯÀÚ°¡ ÀÓ»ó½ÃÇè¿¡ Âü¿©Çϰí ÀÇ·á Á¦°ø¾÷üÀÇ ³×Æ®¿öÅ©¿¡ ¿¬°áÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. Çß½À´Ï´Ù. ´ë±â¾÷ÀÇ À¯»çÇÑ Çõ½ÅÀº ¾÷°è ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°Ô´Ù°¡, ÀϺΠ±ÔÁ¦±â°üµéÀº º¸´Ù ¸íÈ®ÇÑ Áöħ°ú ÇÁ·¹ÀÓ¿öÅ©¸¦ Á¦°øÇϱâ À§ÇØ °¡»ó ½ÃÇè Á¢±Ù¹ýÀ» Áö¿øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó Á¶»ç ¹æ¹ýÀÇ È¿À²¼º°ú ¼Óµµ¸¦ ³ôÀ̱â À§ÇØ ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®°ú ÀÇ»ç°áÁ¤À» ÃËÁøÇÏ´Â °¡»ó ÀÓ»ó½ÃÇèÀÇ Á߿伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ¾÷°èÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°¡»ó ÀÓ»ó½ÃÇè ½ÃÀåÀº ½ÃÇè µðÀÚÀÎ, À¯Çü, ´Ü°è, ÀûÀÀÁõ, »ê¾÷, Áö¿ªÀ¸·Î ºÐ·ùµË´Ï´Ù.

½ÃÇè ¼³°è¿¡ µû¸£¸é °üÂû ½ÃÇè ºÎ¹® ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ 6.7%ÀÇ ¼ºÀå·ü·Î È®´ëµË´Ï´Ù. µðÁöÅÐ ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î ¿ø°ÝÁö¿¡¼­ µ¥ÀÌÅ͸¦ ¼öÁýÇÒ ¼ö ÀÖ¾î ¹°¸®Àû ½Ã¼³ ¹æ¹®À» ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â °üÂû ¿¬±¸°¡ ¼öÇàµÇ±â ½¬¿öÁö°í ÀÖ½À´Ï´Ù. °¡»ó °üÂû ¿¬±¸´Â Âü°¡Àڵ鿡°Ô ´õ¿í Æí¸®Çϰí, ¸ðÁý·ü°ú À¯ÁöÀ²À» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ ½Ç¼¼°èÀÇ µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ¼öÁýÇÒ ¼ö Àֱ⠶§¹®¿¡ ¿¬±¸ °á°úÀÇ Å¸´ç¼º°ú ½Å·Ú¼ºµµ Çâ»óÇϰí ÀÖ½À´Ï´Ù.

»ê¾÷º°·Î´Â ÀÇ·á±â±â ±â¾÷ ºÎ¹®ÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀåÀº 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ Áøº¸·Î ÀÇ·á±â±â ±â¾÷Àº º¸´Ù È¿À²ÀûÀ¸·Î ÀÓ»ó½ÃÇèÀ» ½Ç½ÃÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °¡»ó ÀÓ»ó½ÃÇèÀº ÀüÅëÀûÀÎ ÀÓ»ó½ÃÇè°ú °ü·ÃµÈ ¹°·ù ºÎ´ãÀ» ÁÙÀÌ°í º¸´Ù ½Å¼ÓÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¿¬±¸¸¦ ½ÇÇöÇÕ´Ï´Ù. °¡»ó ÀÓ»ó½ÃÇè ±â¹ý¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀº ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ´õ¿í Çâ»ó½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Áö¿ªº°·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡»ó ÀÓ»ó½ÃÇè »ê¾÷Àº 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.6%¿¡¼­ ÇöÀúÇÑ ¼ºÀåÀ» º¸ÀÔ´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â µðÁöÅÐ °Ç°­ ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ¿ø°Ý µ¥ÀÌÅÍ ¼öÁý°ú ȯÀÚ Âü¿©°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ºÐ»êÇü ÀÓ»ó½ÃÇè Á¢±Ù¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Âü°¡ÀÚÀÇ Á¢±Ù¼º°ú ´Ù¾ç¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÁöÁöÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú °¡À̵å¶óÀÎÀÇ Àü°³°¡, °¡»ó ½ÃÇè ¼ö¹ýÀÇ Ã¤¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù COVID-19 ÆÒµ¥¹ÍÀÇ ¹ß»ýÀº ´ë¸é ±³·ù°¡ Á¦ÇѵǴ °¡¿îµ¥ ¿¬±¸ÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¾Æ½Ã¾ÆÅÂÆò¾ç Àüü¿¡¼­ °¡»ó ½ÃÇèÀ¸·ÎÀÇ À̵¿À» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߰衤¿¹Ãø : Á¶»ç µðÀÚÀκ°(2018-2032³â)

Á¦6Àå ½ÃÀå Ã߰衤¿¹Ãø : À¯Çüº°(2018-2032³â)

Á¦7Àå ½ÃÀå ¿¹Ãø : ÆäÀÌÁ ½ÃÀå Ã߰衤¿¹Ãø : ÆäÀÌÁ(2018-2032³â)

Á¦8Àå ½ÃÀå Ã߰衤¿¹Ãø : ÀûÀÀÁõº°(2018-2032³â)

Á¦9Àå ½ÃÀå Ã߰衤¿¹Ãø : »ê¾÷º°(2018-2032³â)

Á¦10Àå ½ÃÀå Ã߰衤¿¹Ãø : Áö¿ªº°(2018-2032³â)

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Virtual Clinical Trials Market size is projected to expand at 7.1% CAGR from 2024 to 2032. The advancements in digital health technologies and telemedicine are enabling remote data collection, monitoring, and patient engagement while reducing the need for physical site visits and lowering overall costs. To that end, virtual trials have grown largely popular as they offer greater accessibility and convenience for participants, leading to improved patient recruitment, retention, and diversity.

In October 2023, Elligo Health Research collaborated with Avallano to introduce myTrialsConnect, an AI-driven clinical trial recruitment and engagement platform, allowing patients to participate in trials and connect with healthcare providers network. Similar innovations by leading players will positively influence the industry growth.

Additionally, several regulatory agencies are increasingly supporting virtual trial approaches for providing clearer guidance and frameworks. The growing importance of virtual trials in facilitating real-time data analysis and decision-making for enhancing the efficiency and speed of clinical research processes will add to the industry growth.

The virtual clinical trials market is segregated into study design, type, phase, indication, industry, and region.

Based on study design, the market size from the observational segment will expand at 6.7% growth rate from 2024 to 2032. Rapid advancements in digital technologies is enabling remote collection of data, making it easier to conduct observational studies without the need for physical site visits. Virtual observational studies offer greater convenience for participants, leading to improved recruitment and retention rates. The ability to collect real-world data in real-time is also enhancing the validity and reliability of study findings.

In terms of industry, the virtual clinical trials market from the medical devices companies segment is estimated to rise at 7.2% CAGR through 2032. The advancements in remote monitoring technologies is enabling medical device companies to conduct trials more efficiently. Virtual trials reduce the logistical burden associated with traditional trials, ensuring faster and more cost-effective research. The regulatory support for virtual trial methodologies will further boost the segment growth.

Regionally, the Asia Pacific virtual clinical trials industry will showcase significant growth at 7.6% CAGR from 2024 to 2032. The increasing adoption of digital health technologies is facilitating remote data collection and patient engagement in the region. The rising demand for decentralized trial approaches is improving accessibility and diversity of participants. The rollout of supportive regulatory frameworks and guidelines are encouraging the adoption of virtual trial methodologies. Lately, the onset of the COVID-19 pandemic has also accelerated the shift towards virtual trials across APAC for ensuring continuity of research amid restrictions on in-person interactions.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Study Design, 2018 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Phases, 2018 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Industry, 2018 - 2032 ($ Mn)

Chapter 10 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

Chapter 11 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â